Synonyms: cLLB8 | CNTO 328 | Sylvant®
siltuximab is an approved drug (EMA & FDA (2014))
Compound class:
Antibody
|
Selectivity at ligand targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|